JACOB GARY S

Chairman & CEO

C-suiteM

US·SEC (Form 4)

OKYO Pharma Ltd

0

Total declarations

0

Company

€47,264

▲ Purchases (1 ops.)

—

▼ Sales (0 ops.)

Explore the complete record of transactions filed by JACOB GARY S, Chairman & CEO. Director active across 1 companies, notably OKYO Pharma Ltd. In total, 1 disclosures have been logged. Total volume traded: €47k. The latest transaction was filed on 19 May 2022 — Acquisition. Regulator: SEC (Form 4). All data is free.

Declarations1 total

Executives▲PurchaseOOKYO Pharma Ltd◆Signal · 57SEC

J

JACOB GARY SChief Executive Officer

€47,26412,500 shares@ €3.78110.057% mcap100.0% of flow

American Depositary Shares

SEC:0001493152-22-014438:0·19 May 2022

Ideal exit: 13 Feb 2023 (T+270)

SEC ↗

1 of 1 declaration

About JACOB GARY S

Gary S. Jacob is the Chief Executive Officer of OKYO Pharma Ltd. He leads the company with a vision focused on innovation in the pharmaceutical field, aiming to develop innovative treatments for patients.